Why Croda isn’t the first FTSE 100 dividend growth stock I’d buy today

Roland Head looks at the latest figures from Croda International plc (LON:CRDA) and suggests an alternative FTSE 100 (INDEXFTSE:UKX) growth stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at two high quality businesses whose strong growth has propelled them into the blue-chip FTSE 100 index over the last few years. Both are companies I rate highly and would be happy to own at the right price.

A perfect complexion

Speciality chemicals group Croda International (LSE: CRDA) makes a wide range of products including ingredients for cosmetics, agricultural chemicals and chemicals used in lubricants.

The group was the biggest faller in the FTSE 100 on Wednesday morning, down nearly 5%, after it reported a 2.7% drop in sales for the first quarter. This may sound like a disappointing performance for a company with a growth rating, but a closer look suggests things are still on track.

The fall in reported sales was caused by currency headwinds which reduced the sterling value of the group’s sales by 5.3%. Measured at constant exchange rates, group sales rose by 2.6% during the quarter.

The standout performer was the personal care group, where constant currency sales rose by 7.6% in Q1 thanks to strong demand for its beauty products. This division generated 34% of sales and 47% of profits in 2017, so it’s by far the largest and the most profitable part of the company.

Strong outlook

Croda’s speciality chemicals carry high profit margins, perhaps because competition is limited. Last year’s operating margin of 23.7% is in line with previous years and well above the FTSE 100 average.

Broker forecasts put the shares on a 2018 forecast price/earnings ratio of 23 with an expected dividend yield of 2%. This may not seem cheap, but I believe the company’s proven quality justifies a premium. I’d continue to hold after today’s news and would consider buying more if the shares fall further.

One stock I’d buy today

But there’s another share I’d consider buying first. The packaging sector has become larger and more sophisticated in recent years. Retail and industrial demand for bespoke packaging that creates less waste and is cheaper to transport has been boosted further by the growth of internet shopping.

One company that’s profited from this demand is cardboard packaging specialist DS Smith (LSE: SMDS).

This group serves retail and industrial customers throughout much of Europe. It recently expanded into North America with the £722m acquisition of East Coast packaging and paper producer Interstate Resources.

This deal gives DS Smith an entrance route for its products in one of the world’s largest packaging markets. The firm has also recently acquired two firms in Romania, expanding its reach into the European market.

More growth expected

The half-year results showed a return on average capital employed of 14.6%, which is close to the 15% threshold I use to help identify high quality businesses.

Although net debt has risen as a result of Smith’s recent acquisition spree, cash generation has historically been strong. I’m confident management will be able to reduce borrowing to target levels in good time.

Adjusted earnings are expected to rise by 1.9% to 34.4p during the year to 30 April, and by 11.6% to 38.4p in 2018/19. This puts the stock on a forecast P/E of 15, falling to a P/E of 13.4 for the year ahead.

With a twice-covered forecast dividend yield of 3.1%, I believe the shares are attractively valued for medium-term growth. I’d be happy to buy at current levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended DS Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »